Oral β-cyclodextrin insulin microparticles had a promising effect in decreasing the blood glucose in DM rats and the hypoglycemic effect was similar to that of subcutaneous injection of insulin (D’Souza et al., 2015). Here, INS is linked to diabetes mellitus.